Loading
NASDAQHealthcareBiotechnology
Latest quote
$17.83
+$0.13 · +0.73%
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Previous close
$17.83
+$0.13 · +0.73%
After-hours
$17.83
$0.00 · 0.00%
Oct 14, 7:30 PM ET
Regular session · ET · Market data may be delayed.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Day range
Current $17.83
52-week range
Current $17.83
Regular session · ET · Market data may be delayed.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Day range
Current $17.83
52-week range
Current $17.83
Funds reporting this stock among their holdings, ordered by reported position size.
T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFTMED
T. Rowe Price Biotech ETFTDNA
T. Rowe Price Small Cap ETFTSEEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
